Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae

risk assessment
Cite:
Citation Link

European Centre for Disease Prevention and Control. Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae – 12 June 2018.  Stockholm; ECDC; 2018. 

Copy citation to clipboard

This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries. It will outline options for appropriate detection of resistance and the correct and timely implementation of IPC measures to prevent spread of these highly resistant organisms within healthcare settings and across borders.

Related content

Publication

Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis

risk assessment -

Publication

Surveillance of antimicrobial resistance in Europe 2017

surveillance report -

News

ECDC calls for continued action to address antimicrobial resistance in healthcare settings

press release -

Publication

ECDC country visit to Malta to discuss antimicrobial resistance issues, 3-7 July 2017

mission report -

Publication

External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

external quality assessment -